본문으로 건너뛰기
← 뒤로

Necessity of splenectomy for antral-type scirrhous gastric cancer.

1/5 보강
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025 Vol.51(8) p. 108734
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
180 patients were included in this study (antral type, n = 19 [10.
I · Intervention 중재 / 시술
D2 or more total gastrectomy with splenectomy, and in whom R0 or R1 resection was achieved
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The only nodes with an index >0 in the antral type were #4d, #3, #4sb, #6, #7, and #1. [CONCLUSIONS] Splenectomy may therefore be unnecessary for antral-type scirrhous GC.

Fujisaki YY, Yoshikawa T, Ogawa R, Nishino M, Wada T, Hayashi T, Yamagata Y, Tokunaga M, Kinugasa Y, Seto Y

📝 환자 설명용 한 줄

[BACKGROUND] Total gastrectomy with splenic hilar nodal dissection by splenectomy is frequently selected for resectable scirrhous gastric cancer (GC), irrespective of the whether it is of the antral o

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 19
  • p-value p = 0.027

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Fujisaki YY, Yoshikawa T, et al. (2025). Necessity of splenectomy for antral-type scirrhous gastric cancer.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 51(8), 108734. https://doi.org/10.1016/j.ejso.2024.108734
MLA Fujisaki YY, et al.. "Necessity of splenectomy for antral-type scirrhous gastric cancer.." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 51, no. 8, 2025, pp. 108734.
PMID 39428272

Abstract

[BACKGROUND] Total gastrectomy with splenic hilar nodal dissection by splenectomy is frequently selected for resectable scirrhous gastric cancer (GC), irrespective of the whether it is of the antral or body type. However, whether splenectomy is necessary for antral-type scirrhous GC remains unclear.

[METHODS] We retrospectively reviewed the data of patients treated at National Cancer Center Hospital in Japan between 2000 and 2018. We selected patients with type IV GC in which the predominant location could be identified, who received D2 or more total gastrectomy with splenectomy, and in whom R0 or R1 resection was achieved. The therapeutic value index was evaluated by multiplying the metastatic rate of each nodal station by the five-year overall survival (OS) rate of patients with metastasis to each node.

[RESULTS] In total, 180 patients were included in this study (antral type, n = 19 [10.6 %]; body type, n = 161 [89.4 %]). Both types showed similar and frequent invasion of the greater curvature of the upper stomach. Metastasis to the splenic hilar nodes (#10) was not observed in the antral type (0/19) but was observed in the body type (35/161, 21.7 %); the difference was statistically significant (p = 0.027). The therapeutic value index of #10 was 0 in the antral type but was >7, the fourth highest, in the body type. The only nodes with an index >0 in the antral type were #4d, #3, #4sb, #6, #7, and #1.

[CONCLUSIONS] Splenectomy may therefore be unnecessary for antral-type scirrhous GC.

MeSH Terms

Humans; Splenectomy; Stomach Neoplasms; Male; Female; Gastrectomy; Retrospective Studies; Aged; Middle Aged; Lymph Node Excision; Adenocarcinoma, Scirrhous; Survival Rate; Lymphatic Metastasis; Aged, 80 and over; Adult; Neoplasm Staging; Pyloric Antrum